These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8478232)

  • 1. Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
    Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Schwartz G; Saltz L; Dougherty J; Frankel J; Wiseberg J
    Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):821-7. PubMed ID: 8478232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer.
    Minsky BD; Kemeny N; Cohen AM; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
    Cancer; 1991 Jun; 67(11):2859-66. PubMed ID: 2025851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer.
    Minsky B; Cohen A; Enker W; Kelsen D; Kemeny N; Ilson D; Guillem J; Saltz L; Frankel J; Conti J
    Cancer; 1994 Jan; 73(2):273-80. PubMed ID: 8293388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer.
    Minsky BD; Cohen AM; Enker WE; Kelsen DP; Kemeny N; Riechman B; Saltz L; Sigurdson ER; Frankel J
    Int J Radiat Oncol Biol Phys; 1992; 22(1):139-45. PubMed ID: 1727111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.
    Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
    J Clin Oncol; 1992 Jan; 10(1):79-84. PubMed ID: 1727928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.
    Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
    J Clin Oncol; 1992 Aug; 10(8):1218-24. PubMed ID: 1634912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
    Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer.
    Parulekar W; de Marsh RW; Wong R; Mendenhall W; Davey P; Zlotecki R; Berry S; Rout WR; Bjarnason GA
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1487-95. PubMed ID: 15050328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
    Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Liaros A; Athanassiou E; Dombros N; Dervenis C; Basdanis G; Gamvros O; Souparis A; Briasoulis E; Samantas E; Kappas A; Kosmidis P; Skarlos D; Pavlidis N
    Ann Oncol; 1999 Jun; 10(6):671-6. PubMed ID: 10442189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer.
    Minsky BD; Cohen AM; Enker WE; Kelsen DP; Kemeny N; Frankel J
    Cancer Invest; 1995; 13(1):1-7. PubMed ID: 7834464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
    Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Saltz L; Frankel J
    Cancer; 1993 Jun; 71(11):3486-92. PubMed ID: 8490898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer.
    Minsky BD; Cohen AM; Enker WE; Saltz L; Guillem JG; Paty PB; Kelsen DP; Kemeny N; Ilson D; Bass J; Conti J
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):289-95. PubMed ID: 9069299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study.
    Carraro S; Roca EL; Cartelli C; Rafailovici L; Castillo Odena S; Wasserman E; Gualdrini U; Huertas E; Barugel M; Ballarino G; Rodriguez MC; Masciangioli G
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):397-402. PubMed ID: 12243813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer.
    Grann A; Minsky BD; Cohen AM; Saltz L; Guillem JG; Paty PB; Kelsen DP; Kemeny N; Ilson D; Bass-Loeb J
    Dis Colon Rectum; 1997 May; 40(5):515-22. PubMed ID: 9152176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
    de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297.
    Rosenthal DI; Catalano PJ; Haller DG; Landry JC; Sigurdson ER; Spitz FR; Benson AB
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):108-13. PubMed ID: 18722265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorouracil and high-dose leucovorin with radiotherapy as adjuvant therapy for rectal cancer. Results of a phase II study.
    Giralt J; Rubio D; Maldonado X; Naval J; Casado S; Lara F; Roselló JM; Armengol M
    Acta Oncol; 1997; 36(1):51-4. PubMed ID: 9090966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
    Kelsen DP; Saltz L; Cohen AM; Yao TJ; Enker W; Tong W; Tao Y; Bertino JR
    Cancer; 1994 Oct; 74(8):2224-33. PubMed ID: 7922973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitomycin-C/5-fluorouracil/leucovorin and hyperfractionated radiation therapy for rectal carcinoma: a phase II study with long-term follow-up.
    Nabhan C; Ragam A; Samuels B; Milton DT; Prasad L; Hooberman A; Hartsell W; Anthony A; Weisman R; Bitran JD
    Clin Colorectal Cancer; 2007 Mar; 6(6):436-41. PubMed ID: 17531107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.
    Grem JL; McAtee N; Murphy RF; Balis FM; Steinberg SM; Hamilton JM; Sorensen JM; Sartor O; Kramer BS; Goldstein LJ
    J Clin Oncol; 1991 Oct; 9(10):1811-20. PubMed ID: 1919632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.